Clinical Trials Browser

OTHER × Urinary Bladder Neoplasms × tipifarnib × Clear all

NCT00047216 2015-07-23

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms